Abstract

Recently, several anti-inflammatory peptides (AIPs) have been found in the process of the inflammatory response, and these peptides have been used to treat some inflammatory and autoimmune diseases. Therefore, identifying AIPs accurately from a given amino acid sequences is critical for the discovery of novel and efficient anti-inflammatory peptide-based therapeutics and the acceleration of their application in therapy. In this paper, a random forest-based model called iAIPs for identifying AIPs is proposed. First, the original samples were encoded with three feature extraction methods, including g-gap dipeptide composition (GDC), dipeptide deviation from the expected mean (DDE), and amino acid composition (AAC). Second, the optimal feature subset is generated by a two-step feature selection method, in which the feature is ranked by the analysis of variance (ANOVA) method, and the optimal feature subset is generated by the incremental feature selection strategy. Finally, the optimal feature subset is inputted into the random forest classifier, and the identification model is constructed. Experiment results showed that iAIPs achieved an AUC value of 0.822 on an independent test dataset, which indicated that our proposed model has better performance than the existing methods. Furthermore, the extraction of features for peptide sequences provides the basis for evolutionary analysis. The study of peptide identification is helpful to understand the diversity of species and analyze the evolutionary history of species.

Highlights

  • As a part of the nonspecific immune response, inflammation response usually occurs in response to any type of bodily injury (Ferrero-Miliani et al, 2007)

  • The results show that the combined features of amino acid composition (AAC) + deviation from the expected mean (DDE) + gap dipeptide composition (GDC)-gap1 have the best performance on the independent dataset

  • An identifying anti-inflammatory peptides (AIPs) model based on peptide sequence is proposed

Read more

Summary

Introduction

As a part of the nonspecific immune response, inflammation response usually occurs in response to any type of bodily injury (Ferrero-Miliani et al, 2007). The therapy for inflammatory and autoimmune diseases usually uses nonspecific anti-inflammatory drugs or other immunosuppressants, which may produce some side effects (Tabas and Glass, 2013; Yu et al, 2021). Several endogenous peptides found in the process of inflammatory response have become anti-inflammatory agents and can be used as new therapies for autoimmune diseases and inflammatory disorders (Gonzalez-Rey et al, 2007; Yu et al, 2020a). Compared with small-molecule drugs, the therapy based on peptides has minimal toxicity and high specificity under normal conditions, which is a better choice for inflammatory and autoimmune disorders and has been widely used in treatment (de la Fuente-Núñez et al, 2017; Shang et al, 2021). The experimental result shows that our proposed method in this paper has better performance than the existing methods

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call